The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3

IMR Press is a leading publisher of open access peer-reviewed biomedical and life sciences journals. We aim to facilitate the dissemination of high-quality research in the area of biomedical science. With a long tradition and wide readership, IMR Press is dedicated to making positive contributions to academics, corporate libraries as well as to readers and authors. All the editors in IMR Press will provide the best service for researchers, allowing them to have a easy and smooth publication experience and helping maximize the impact and visibility of their research.

Cardiorenal Syndrome - ScienceDirect

Cardiorenal syndrome type 1 and cardiorenal syndrome type 3. (a

Advances in pathogenesis and current therapeutic strategies for

Wnt/β-catenin signaling mediates both heart and kidney injury in

Kidney and heart interactions during cardiorenal syndrome: a

Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis

Type 3 Cardiorenal Syndrome

Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis

Cardio renal syndrome - Cancer Therapy Advisor

Frontiers Immunomodulatory Approaches in Diabetes-Induced

Frontiers The molecular mechanisms and intervention strategies

Cardiorenal syndrome: Multi‐organ dysfunction involving the heart

Hypoxia and chronic kidney disease - eBioMedicine

Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading

Contemporary Management of Severe Acute Kidney Injury and